|
 “Our findings confirm socioeconomic inequalities in prescription of
anticoagulants,” lead study author Maria Sjolander, a researcher in
statistics and pharmacology at Umea University, said by email.
The researchers studied roughly 12,000 first-time stroke patients
who also had a heart rhythm disorder known as atrial fibrillation
that raises stroke risk and found just 36 percent of them were
prescribed anticoagulant drugs when they left the hospital.
But only 11 percent of patients in their 90s and older and 29
percent of people in their 80s received the drugs, compared with 61
percent of adults under age 70, the study found.
Roughly 30 percent of the poorest patients and people without a high
school education got the medicine, compared with 48 percent of
college-educated patients and 46 percent of the richest stroke
survivors.
Globally, 15 million people suffer strokes each year; five million
of them die and another five million are left permanently disabled,
according to the World Health Organization. Initial symptoms can
include drooping or numbness on one side of the face, lack of
feeling or mobility in one arm, and slurred or impaired speech.
Millions of people worldwide have atrial fibrillation (AF), which
happens when rapid, disorganized electrical signals cause the
heart’s two upper chambers called the atria to contract very quickly
and irregularly. This stops blood from pumping completely into the
heart’s lower chambers, or ventricles, and prevents both parts of
the organ from working together properly. Symptoms can come and go.
When people do have symptoms of atrial fibrillation they also have
an increased stroke risk because the rapid heartbeat allows blood to
pool in the heart, which can cause clots to form then travel to the
brain.
Anticoagulants, often described blood thinners, work by preventing
the formation of blood clots. The drugs block the production of
vitamin K in the liver, which increases the time blood takes to
clot. The drugs don’t actually thin the blood, but they can reduce
the risk of strokes by stopping clots from getting larger.
One side effect, however, is that the drugs also make it difficult
to stop bleeding when people are cut or injured.
“The fear of bleeding is high among physicians, especially for the
elderly, even though the data clearly indicate that in elderly
patients the net clinical benefit of anticoagulants is particularly
high due to their elevated stroke risk,” said Dr. Daniela Poli a
researcher at the Thrombosis Centre, Azienda Ospedaliero
Universitaria Careggi, in Florence, Italy.
[to top of second column] |
Anticoagulants can reduce the risk of stroke by about 70 percent,
while the risk of bleeding from anticoagulants is around 1-2 percent
per year and slightly higher in the elderly, Poli, who wasn’t
involved in the study, said by email.
One limitation of the study, the researchers acknowledge in the
American Heart Association journal Stroke, is that they lacked data
on the severity of the patients’ strokes and on other medical
conditions that might make anticoagulants less likely to be
prescribed or unsafe to take.
Even so, it’s not surprising that elderly patients were less likely
to get drugs than the young, said Dr. Mark Metersky, a professor in
the division of pulmonary and critical care at the University of
Connecticut School of Medicine in Farmington.
“Elderly patients are more likely to have risk factors for bleeding
from anticoagulation, for example tendency to fall, that prevents
doctors from prescribing them,” Metersky, who wasn’t involved in the
study, said by email.
Physicians might also find it too risky to give these drugs to less
educated people out of concern that these patients might not take
the medicine as prescribed. Or these patients might be treated at
lower quality institutions than their wealthier peers, he said.
But if patients don’t get the drugs, they should speak up.
“Patients who have atrial fibrillation who are not on an
anticoagulant should discuss with their doctor if they could lower
their risk of stroke without exposing themselves to excessive risk,
by being started on anticoagulation,” Metersky said.
SOURCE: http://bit.ly/1QU5wBg Stroke, online June 16, 2015.
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
